CoVerified

CoVerified launched their MVP as a basic dashboard aggregating COVID-19 test results and vaccine records for organizations reopening offices. ​​‌‌‌‌‌‌‌​‌‌​​‌​​​​​​‌‌​‌‌‌​​​‌‌They shipped within weeks of founding, prioritizing speed over infrastructure. The team deliberately omitted sophisticated data security features, assuming they could retrofit compliance later—a critical miscalculation in healthcare. They also skipped building direct integrations with major lab systems, instead relying on manual uploads and third-party APIs. This execution velocity initially impressed investors during YC Winter 2021, but it masked fundamental problems. CoVerified's founders missed warning signs that their market was collapsing: vaccination rates climbed rapidly, mandates faced legal challenges, and organizations abandoned reopening plans. Their lean approach meant they lacked the regulatory expertise to navigate HIPAA requirements properly, forcing expensive pivots. By prioritizing speed over understanding healthcare's regulatory complexity and market timing, CoVerified built a product for a crisis that was already ending. The company went inactive within months, proving that some markets demand deliberate caution over startup velocity.